We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Gut Segments Reunite in Model Culture System

By LabMedica International staff writers
Posted on 07 Sep 2015
Print article
Image: Embryonic bowel explants were cultured for three days in basal media alone or this media supplemented with R-Spondin 1. Note that, in the latter condition, there was exuberant growth of tissue from the ends of explants. Bars are 250 microns long (Photo courtesy of the University of Manchester).
Image: Embryonic bowel explants were cultured for three days in basal media alone or this media supplemented with R-Spondin 1. Note that, in the latter condition, there was exuberant growth of tissue from the ends of explants. Bars are 250 microns long (Photo courtesy of the University of Manchester).
An organ culture model system was created to evaluate physical manipulations aimed at enhancing the healing of gut segments in order to generate a single functional organ.

Investigators at the University of Manchester (United Kingdom) worked with embryonic mouse jejunum, which was isolated and cut into tubes two to three millimeters in length. The paired segments separated by a small gap (about one millimeter) were placed in growth medium on semi-permeable supports. Each pair of segments was linked by a nylon suture threaded through their lumens.

Results published in the August 3, 2015, online edition of the Journal of Tissue Engineering and Regenerative Medicine revealed that after three days in organ culture fed by defined serum-free media, the rudiments differentiated to form tubes of smooth muscle surrounding a core of rudimentary villi. Of 34 such pairs, 74% had touching and well aligned proximate ends. Of these joined structures, 80% (59% of the total pairs) had a continuous lumen, as assessed by observing the trajectories of fluorescent dextrans injected into their distal ends. Fused organ pairs formed a single functional unit, as assessed by spontaneous contraction waves propagated along their lengths.

In some experiments the investigators added a growth factor called R-spondin 1 to the medium in an attempt to accelerate growth and make it more successful. Although this caused faster growth, it failed to establish the bridge in as uniform a way and fusion was less successful.

Senior author Dr. Adrian Woolf, professor of pediatric science at the University of Manchester, said, "The ability to study organs outside of the body is delivering new insights into how they work. In this case we have been able to study damaged intestines and instigate repairs which could lead to treatment in a number of conditions. In this study we managed to bridge a gap of less than one millimeter, but for this to be useful in conditions like short bowel syndrome we will need to promote growth across much larger distances. Having the ability to test different vitamins and hormones which promote growth opens up many new possibilities for future treatments."

Related Links:

University of Manchester


Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Typhoid Rapid Test
OnSite Typhoid IgG/IgM Combo Rapid Test
New
Hemoglobin/Haptoglobin Assay
IDK Hemoglobin/Haptoglobin Complex ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.